2012 Session Titles

The ATS International Conference Program offers the latest in pulmonary, critical care and sleep medicine for ATS members and other physicians, scientists and healthcare professionals.

Following are lists of postgraduate courses, scientific symposia, track sessions, seminars and workshops offered at ATS 2012 • San Francisco.

FRIDAY, MAY 18

POSTGRADUATE COURSES
8:00 am – 4:00 pm

PG1	Pulmonary Adaptive Immunity: More Than Just Crossing Your T's
PG2	Grant Fundamentals For Clinical, Community, And Public Health Researchers
PG3	Lung Cancer: State Of The Art In 2012
PG4	Intensive Care Unit Monitoring
PG5	Pulmonary And Critical Care Reviews: Built Around ABIM 2011 Modules (Updates) In Pulmonary And Critical Care
PG6	Incorporating Ultrasound And Echocardiography Into Intensive Care Unit Practice
PG7	Epigenetics Of Lung Diseases
PG8	Difficult Clinical Problems In Pulmonary Infections
PG9	The Cellular Foundation Of Pediatric Respiratory Disease
PG10	Sleep Disordered Breathing And Associated Co-Morbidities In Children: From Bench To Bedside
PG11	New Science In The Comprehensive Management Of The Chronic Obstructive Pulmonary Disease Patient
PG12	Case-Based Pulmonary Function Test (PFT) Interpretation: The Foundations
PG13	What’s New In Obstructive Sleep Apnea And Cardiovascular Disease?
PG14	Leadership Workshop: Developing Skills To Advance Your Career And Improve Your Work Environment. Day 1

SATURDAY, MAY 19

POSTGRADUATE COURSES
8:00 am – 4:00 pm

PG15	Enhancing Patient Centered Care And Improving Outcomes Through Motivational Interviewing: A Hands On Course- CANCELLED
PG16	Thoracic Imaging
PG17	Management Of Interstitial Lung Disease: A Case-Based Approach
PG18	Exacerbations Of Chronic Obstructive Pulmonary Disease: Measurement, Mechanisms, Modeling And Management
PG19	Novel Approaches To Investigate Occupational And Environmental Causes In Common Lung Diseases
PG20	Host Defense Mechanisms In Pulmonary Infection
PG21	The Physiologic Basis Of Pediatric Respiratory Diseases
PG22	Update In Pulmonary Arterial Hypertension: What's New, What's Now
PG23	Update On Venous Thromboembolism
PG24	Cardiopulmonary Exercise Testing (CPET): An Evidence And Case-Based Update 2012
PG25	Master Physiology Class: Common Pulmonary Diseases From A Physiologic Perspective
PG26	Current And Emerging Treatments For Sleep Disordered Breathing
PG27	Mastering Clinical Teaching Skills For Pulmonary And Critical Care
PG28	Leadership Workshop: Developing Skills To Advance Your Career And Improve Your Work Environment. Day 2
PG29	American Thoracic Society Bronchoscopy Course

SUNDAY, MAY 20

HANDS-ON LUNG BIOPSY SKILLS WORKSHOP
7:00 am - 12:00 pm

H1	Hands-On Lung Biopsy Skills Workshop: Mutational Testing In The Era Of Personalized NSCLC Therapy

YEAR IN REVIEW
8:15 am – 10:15 am

A1	Clinical Year In Review 1

CLINICAL TOPICS IN PULMONARY MEDICINE
8:15 am – 10:45 am

A2	Evaluation Of Interstitial Lung Disease: More Bang For Your Buck
A3	Fellows Case Conference

CRITICAL CARE TRACK
8:15 am – 10:45 am

A4	What Do You Do Now? Clinical Challenges At The Edge Of The Evidence

SCIENTIFIC SYMPOSIA
8:15 am – 10:45 am

A5	Dyspnea Update And The Road Ahead
A6	The Price Of Progress: Lung Injury Before And After Pediatric Lung Transplantation
A7	Airway Remodeling And Hyperresponsiveness In Asthma: What Are They And What Can We Do About Them?
A8	ARRA-Funded Lung Stem And Progenitor Cell Projects
A9	Epigenetics At The Crossroads: The Intersection Between The Lung And The Environment
A10	HIV-Associated Pulmonary Complications In The Era Of Antiretroviral Therapy
A11	Adult Cystic Fibrosis: The Essentials
A12	Discussion On The Edge: Reports Of Recent Pulmonary Research Published In The New England Journal Of Medicine Or The Journal Of The American Medical Association

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 am – 10:45 am

A13	Advances In COPD Pathogenesis And Exacerbation Susceptibility
A14	Tuberculosis Host Defense
A15	Airway Responses To Respiratory Viral Infection
A16	The Matrix In Control: Pathobiology Driven By Matrix Remodeling And Rigidity
A17	Pathogenic Mechanisms Of Acute Lung Injury
A18	Obstructive Sleep Apnea: Interventions And New Associations
A19	Novel Insights And Novel Approaches: Late Breaking Abstracts
A21	First Responders: Mucosal Innate Immunity
A22	Psychosocial Factors Associated With Respiratory Health Outcomes
A23	Novel Technology In Interventional Pulmonology
A24	Clinical Sepsis
A25	Predicting Development And Outcomes In Acute Lung Injury
A26	Work-Related Lung Disease: Clinical And Epidemiological Approaches
A27	Health Effects Of Nanoparticles
A28	Lung Development: Bench To Bedside
A29	Pathogenesis Of Pulmonary Hypertension
A30	Pulmonary Vices: Cigarette Smoke, Alcohol And Oxidative Stress Responses Of The Lung

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 AM – 4:30 PM

A31	Pathogenesis Of COPD And Emphysema In Mice And Men
A32	Smoke-Related Alterations In Lung Biology
A33	Acute Lung Injury
A34	New Insights Into Sarcoidosis
A35	Recent Advances In Phagocyte Biology
A36	Cytokines And Chemokines In Airways Disease
A37	Lipids In Lung Diseases
A38	Microbial Influences On Asthma And COPD
A39	Improving Quality In The Intensive Care Unit
A40	The Economic Burden Of Respiratory Disease And Cost- Effectiveness Of Treatments
A41	COPD: What's The Score?
A42	COPD: Phenotypes And Outcomes
A43	COPD: Functional Assessment And Exercise
A44	Topics In Benign And Malignant Pleural Disease
A45	Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases
A46	Intensive Care Unit Management And Rapid Response: Provider And Patient Outcomes
A47	Diagnostic Techniques And Monitoring
A48	Mechanical Ventilation
A49	Air Pollution: Respiratory And Novel Health Effects
A50	Health Effects Of Indoor Air Pollutants
A51	Diet, Overweight, Diabetes And Lung Disease
A52	Differentiating Health Care Associated Pneumonia From Community Acquired Pneumonia
A53	Epidemiology, Risk Factors, And Outcomes Of Respiratory Infections
A54	Assessing Severity Of Disease In Patients With Community Acquired Pneumonia
A55	Lung Development And Chronic Lung Disease Of Prematurity
A56	Pediatric And Neonatal Critical Care
A57	Pulmonary Barriers To Edema Formation
A58	Clinical Evaluation Of Pulmonary Hypertension
A59	Fibroblast Biology Reloaded
A60	COPD: Omics
A61	Antifibrotics And Therapeutic Targets In Experimental Lung Fibrosis
A62	New Insights In Acute Lung Injury: In Vivo And In Vitro
A63	New Concepts In The Alveolar Surfactant Structure And Function
A64	Local And Systemic Effects Of Smoke Exposure
A65	Lung Imaging: Physiology And Technology
A66	Modeling, Mechanics And Gas Exchange
A67	Acute Lung Injury And Acute Respiratory Distress Syndrome: Biological Mechanisms
A68	Tissue Remodeling In The Lung
A69	Neural Control Of The Airway
A70	Sleep Disordered Breathing: Cardiovascular And Metabolic Aspects

WORKSHOPS
11:30 am – 1:00 pm

WS1	Endobronchial Ultrasound Workshop
WS2	Mycobacterial And Fungal Diagnostics

SESSIONS BY OTHER ORGANIZATIONS
12:00 pm – 1:00 pm

L1	Tips From The Other Side: Making Grant Applications Attractive To The National Institute Of Nursing Research
L2	Pulmonary Update From The U.S. Food And Drug Administration
L3	NASA’S Satellites And Their Use In Studying The Environement And Diseases
L4	The NIAID Human Immunology Project Consortium: Influenza And Systems Biology
L5	Update From CDC's TB Trials Consortium (TBTC) And TB Epidemiologic Studies Consortium (TBESC)
L6	Infant Study Of Inhaled Saline In Cystic Fibrosis (ISIS)
L7	The Lung HIV Microbiome Project: Validation, Healthy Volunteers, And Diseased States
L8	NHLBI Childhood Asthma Research And Education (CARE) Network: New Study Findings
L9	Effects Of Adenotonsillectomy On Health Outcomes In Children With Sleep Apnea: Results From The Childhood Adenotonsillectomy (CHAT) Study
L26	Developmental Origins of Asthma: Primary Prevention Strategies

MEET THE PROFESSOR SEMINARS
12:00 pm – 1:00 pm

MP401	Managing Asthma Phenotypes For The Clinician
MP402	Does Addressing Health Literacy Improve Health Outcomes?
MP403	Prevention Of COPD Exacerbations: Current And Novel Approaches
MP404	Autoantibodies And Lung Disease
MP405	Bronchiectasis: Case Based Approach To Diagnosis And Treatment
MP406	Diagnosing And Managing Interstitial Lung Disease In The Elderly Patient
MP407	Advances In Adult Cystic Fibrosis For The Non-CF Physician
MP408	Role Of The Pulmonary Intensivist In The Paradigm Of Accountable Care Organizations
MP409	Malignant Pleural Effusion: What Are My Options?
MP410	Achieving Zero CLABSI Rates In Your ICU
MP411	Tuberculosis And The TNF-Alpha Inhibitors
MP412	Non-Pharmacologic Intervention For Insomnia Co-Morbid With Chronic Illness
MP413	Pediatric Mechanical Ventilation
MP414	Surgical Risk Assessment And Management In The Patient With Pulmonary Hypertension
MP415	The Do's And Don'ts Of A K08 Application
MP416	Obesity And Asthma Overlap: Insight Into Pathophysiology And Treatment Strategies
MP417	Developing New ATS/ERS Recommendations For Methacholine Challenge Testing
MP418	Women And Sleep

THEMATIC SEMINAR SERIES
12:00 pm – 1:00 pm

TSS1	Chronic Obstructive Pulmonary Disease

OUTSTANDING RESEARCH PROGRAM
2:00 pm – 4:30 pm

A81	Scientific Breakthroughs Symposium: Biomarkers For Lung Disease: The Cutting Edge

CLINICAL TOPICS IN PULMONARY MEDICINE
2:00 pm – 4:30 pm

A82	Emerging Science Of Non-Cystic Fibrosis Bronchiectasis
A83	Great Cases: Clinical, Radiologic And Pathologic Correlations By Master Physicians

SCIENTIFIC SYMPOSIA
2:00 pm – 4:30 pm

A85	The IL33/ST2 Axis: New Biology And New Potential Targets In Asthma
A86	Neonatal Origins Of Adult Pulmonary Disease
A87	Arrhythmogenesis And Cardiac Disease In Sleep Disordered Breathing: Mechanisms And Clinical Implications
A88	Microparticles: Small Wonders Or A Big Deal In Pulmonary Injury And Disease?
A89	Novel Inflammatory And Repair Pathways In Chronic Obstructive Pulmonary Disease
A90	Pediatric Non-Invasive Ventilation
A91	Advances in Lung Transplant
A111	Drugs, Regulatory Agencies and Guidelines: The Challenge of Idiopathic Pulmonary Fibrosis

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
2:00 PM – 4:30 PM

A92	Severe Asthma: Present And Future
A93	Identifying Risk Factors And Potential Interventions For Asthma Adherence
A94	The New Biology Of Sepsis
A95	Hygiene Hypothesis Revisited
A96	Transitions In Health Care Setting, Disease Management, And Disease State
A97	Modeling Remodeling: How Disease Affects The Airways
A98	Nanotech Meets The Lung
A101	Pharmacological Treatment Of Copd: Old And New
A102	Long-Term Outcomes After Critical Illness
A103	Health Services Research And Administrative Databases
A104	Tuberculosis In Vulnerable Populations
A105	Evaluation Of Pediatric Lung Diseases
A106	Advances In Diagnosis And Treatment Of Pulmonary Embolism
A107	Assessment, Exercise Training And Outcomes
A108	Airways Hyperresponsiveness: Causes And Treatments
A109	Upper Airway Control, Structure And Function
A110	Emerging Insights Into Obstructive Lung Disease: Late Breaking Abstracts

MONDAY, MAY 21

SUNRISE SEMINARS
7:00 am – 8:00 am

SS101	Eosinophils: Friend Or Foe In Pulmonary Disease?
SS102	Pulmonary Hypertension In Interstitial Lung Disease
SS103	Diagnosing And Treating Collagen Vascular Associated Interstitial Lung Disease
SS104	Optimizing Efficiency And Yield With EBUS-TBNA
SS105	What Is My Pathologist Trying To Tell Me?
SS106	Optimizing The Patient For Lung Transplantation
SS107	Acute COPD Exacerbation Phenotypes: Recognition And Treatment
SS108	Liberation From Mechanical Ventilation: Beyond Weaning Parameters
SS109	Real-World Spirometry: Pitfalls That Falsely Elevate (Or Reduce) Results
SS110	Infectious Etiologies Of Asthma And Asthma Exacerbation
SS111	Dyspnea Crisis: Translation Into Practice
SS112	Management Of Emerging Drug-Resistant Strains Of Bacteria That Cause Pneumonia In Children
SS113	Pulmonary Complications Of Liver Disease
SS114	Contemporary Techniques For Epigenetic And Epigenomic Studies In Lung Disease
SS115	Practical Integration Of Novel And Established Imaging Techniques For The Diagnosis And Staging Of Lung Cancer
SS116	The Use Of Image Analysis In Quantifying The Pathology Of Lung Diseases
SS117	What The Pulmonologist Should Know About Sleep In Respiratory Disease

THEMATIC SEMINAR SERIES
7:00 am – 8:00 am

TSS1	Chronic Obstructive Pulmonary Disease
TSS2	Drug-Induced Lung Disease

HANDS-ON LUNG BIOPSY SKILLS WORKSHOP
7:00 am - 12:00 pm

H2	Hands-On Lung Biopsy Skills Workshop: Mutational Testing In The Era Of Personalized NSCLC Therapy

YEAR IN REVIEW
8:15 am – 10:15 am

B1	Clinical Year In Review 2

CLINICAL TOPICS IN PULMONARY MEDICINE
8:15 am – 10:45 am

B2	Chronic Obstructive Pulmonary Disease Exacerbations: Lessons Learned From Clinical Trials
B3	Pushing The Envelope: Reevaluating The Criteria For Lung Transplant Candidate Selection

CRITICAL CARE TRACK
8:15 am – 10:45 am

B4	An Ounce Of Prevention In Critical Care

SCIENTIFIC SYMPOSIA
8:15 am – 10:45 am

B5	Idiopathic Interstitial Pneumonias/Pulmonary Fibrosis: Is 'Idiopathic' Truly 'Idiopathic'?
B6	Controversies In The Treatment Of Childhood Asthma: A Pro-Con Debate
B7	Controversies In The Diagnosis And Management Of Obstructive Sleep Apnea: Cutting Edge Debates
B8	The Updated ATS/ERS Statement On Pulmonary Rehabilitation
B9	Targeting The Alveolome: Intercellular Crosstalk In Alveolar Injury, Repair, And Therapy
B10	Non-Tuberculous Mycobacteria Update: Guidelines Plus 5
B11	Probing The Lung Microbiome In Health And Disease
B12	Improving Care For Severe Sepsis In Resource-Limited Settings
B13	Discussion On The Edge: Reports Of Recent Critical Care Research Published In The Journal Of The American Medical Association Or The New England Journal Of Medicine

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 am – 10:45 am

B14	Control Of Innate And Adaptive Immunity In The Lung
B15	Clinical Outcomes Research Methodology
B16	Cystic Fibrosis: Novel Therapies And Outcome Measures
B17	How Bad Is Traffic Pollution? Health Effects And Interventions
B18	Rare Pediatric Lung Disease: Expanding Our Understanding
B19	Update In Clinical Trials Of Pulmonary Arterial Hypertension
B20	Emerging Approaches To Respiratory Infections: Late Breaking Abstracts
B21	Genetics Of Asthma
B22	Advances In The Treatment Of Lung Cancer
B23	Outcomes, Health Services And Patient-Centered Research In The Intensive Care Unit
B24	Process Improvement: Impact On Outcomes Of Patients With Pneumonia
B25	Smoking Across The Research Spectrum: Symptoms, Genetics, And Quality Of Life
B26	Pulmonary Vascular Signaling In Pulmonary Hypertension
B27	Balancing Act: Novel Functions Of The Protease And Antiproteases In The Lung
B28	Emerging Biomarkers Of Complex Lung Diseases
B29	The Lung On The Border Between Order And Chaos
B30	Mechanisms Of Muscle Weakness In Critical Illness: Translating Basic Science To The Bedside

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 AM – 4:30 PM

B31	Environmental Exposures That Influence Lung Function
B32	Test Your Diagnostic Skills: Interesting Cases
B33	Asthma Therapy: Novel Approaches
B34	Inflammatory Mechanisms In Asthma
B35	Pathogenesis And Clinical Issues In Cystic Fibrosis
B36	Airway Hyperresponsiveness
B37	New Insights Into Asthma And COPD Treatment
B38	Barriers To Self-Management And Access To Care And Strategies To Overcome Them
B39	Current Practices In Medical Education: Residents To Practicing Physicians
B40	Lung Volume Reduction In COPD
B41	COPD: Pharmacological Treatment
B42	Case Reports: General Pulmonary
B43	Endobronchial Ultrasound: Diagnostic Applications
B44	Advances In The Diagnosis And Treatment Of Sarcoidosis
B45	Exacerbations Of COPD: Prevention, Treatment And Outcomes
B46	Acute Respiratory Distress Syndrome And Ventilator Induced-Lung Injury: Bench To Bedside Advances
B47	Intensive Care Unit Physiotherapy And Weaning: Mind Over Muscle?
B48	Non-Invasive Ventilation
B49	Non-Pulmonary Critical Care
B50	Clinical Trials In The Intensive Care Unit
B51	Air Pollution And Temperature: Cardiovascular Effects
B52	Recognizing Occupational And Environmental Lung Disease: Clinical And Exposure Assessment
B53	Asthma Epidemiology: Trends And Risk Factors
B54	Tuberculosis In Special Populations
B55	Host Defense In Pulmonary Infection And Tuberculosis
B56	Pathogenesis And Host Response To Fungal Lung Infections
B57	Improving Outcome In Tuberculosis
B58	Tuberculosis Education And Surveillance
B59	Asthma: Devices, Adherence, And Health Outcomes
B60	Nursing In Pulmonary And Critical Care
B61	Pediatric Asthma
B62	Pediatric Clinical Cases
B63	Experimental Models In Pulmonary Hypertension I
B64	Right Ventricle In Pulmonary Vascular Disease
B65	Epigenetic Regulation Of Lung Cell Function
B66	The Fibroblast Pool On The Move: Derivation And Targeting
B67	Ion Transport In Lung Cells: Impact On Lung Function And Disease
B68	Lung Structure And Growth
B69	Airway Structure And Function
B70	Sleep Disordered Breathing: Pathophysiology

WORKSHOPS
11:30 am – 1:00 pm

WS3	Career Development Workshop: Grantsmanship Skills For Basic Science And Translational Researchers: What Happens During Grant Review?
WS4	Case Based Approach To Diagnosing And Treating Patients With Non-Tuberculous Mycobacterium Lung Infections

SESSIONS BY OTHER ORGANIZATIONS
12:00 pm – 1:00 pm

L10	Challenges And Progress In Understanding Community-Acquired Pneumonia: : The CDC Epic Study
L11	Fogarty International Center Research And Research Training Opportunities
L12	The Role Of The Microbiome And Epigenetics In Inner City Asthma
L13	Get To Know NIGMS The National Institute Of General Medical Sciences
L14	NIOSH Update On Classifying Digital Chest Images Of Pneumoconioses
L15	Update On NHLBI ARDS Network: Ancillary Studies
L16	COPD-Clinical Research Network Clinical Trials Update: Azithromycin In Exacerbations Prevention And Response To Pneumococcal Vaccinations
L17	Findings From NHLBI Severe Asthma Research Program: Dissecting Heterogeneity Of Severe Asthma
L27	COPD Guidelines and Treatment Initiatives Update

MEET THE PROFESSOR SEMINARS
12:00 pm – 1:00 pm

MP501	Comprehensive Management Of The Patient With Idiopathic Pulmonary Fibrosis
MP502	Lung Cancer Staging In 2012
MP503	Clinical Problems In Sarcoidosis
MP505	Pulmonary Diseases Associated With Elevated IGE
MP506	Coding For Pulmonary Function Testing: New Codes For Old Tests
MP507	Pulmonary Artery Catheterization For The Pulmonologist: Practical Tips
MP508	Predictably Irrational: Revealing The Hidden Forces That Drive End Of Life Decisions
MP509	Pulmonary Infections After Disasters
MP511	Measurement Issues In COPD
MP512	Viral Infections And Childhood Asthma
MP513	Management Of The Patient With A Submassive Pulmonary Embolism: Evolving Concepts
MP514	Maintaining Quality In Pulmonary Rehabilitation
MP515	The Process Of Writing And Reviewing A Scientific Article
MP516	Gene Therapy For Lung Diseases: A Postponed Dream Whose Time Has Come?
MP517	Similarities And Differences In Asthma And COPD: Are They Real?
MP518	A Practical Approach To Improving Adherence To Positive Airway Pressure Therapy In Patients With Obstructive Sleep Apnea

THEMATIC SEMINAR SERIES
12:00 pm – 1:00 pm

TSS1	Chronic Obstructive Pulmonary Disease
TSS2	Drug-Induced Lung Disease

YEAR IN REVIEW
2:00 pm – 4:30 pm

B81	Pediatric Year In Review

CLINICAL TOPICS IN PULMONARY MEDICINE
2:00 pm – 4:30 pm

B82	The Many Faces Of Bronchiolitis Obliterans: New Insights From Occupational Medicine To Human Transplantation
B83	Immunotherapy For Lung Cancer And Mesothelioma

CRITICAL CARE TRACK
2:00 pm – 4:30 pm

B84	Extracorporeal Gas Exchange: Respiratory Failure And Beyond

SCIENTIFIC SYMPOSIA
2:00 pm – 4:30 pm

B85	Divergent Roles Of Antigen Presenting Cells In Lung And Health Disease
B86	Targeting The Extracellular Matrix: Detecting And Treating Fibrotic Diseases
B87	Everything You Always Wanted To Know About Your Patient (But Were Afraid To Ask)
B88	Work-Exacerbated Asthma: New Developments In Clinical Approach, Epidemiology, And Prevention
B89	Ubiquitination And Proteolysis In Respiratory Disease
B90	Going For The Cure: The Mycobacteria Case
B91	Career Development Symposium: The Evolution of Academic Medicine

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
2:00 pm – 4:30 pm

B92	Asthma Phenotypes: Better Understanding Of Asthma And Rationale For Therapy
B93	Clinical Trials In Idiopathic Pulmonary Fibrosis And Sarcoidosis
B94	Neuromuscular, Cognitive And Psychiatric Issues In The Intensive Care Unit
B95	Bench To Bedside Advances In Bronchiectasis
B96	Mechanisms And Markers Of Pulmonary Endothelial Barrier Disruption And Repair
B97	Pulmonary Rehabilitation: The Best Of The Best
B98	Novel Approaches To Lung Imaging
B101	Pathogenesis Of Acute Lung Injury
B102	COPD: Challenges Affecting Diagnosis, Treatment, And Health Outcomes
B103	COPD: Mechanisms Of Disease Progression And Exacerbation
B104	Lung Transplantation: Patient Selection, Complications, And Outcomes
B105	Devices And Monitoring In The Intensive Care Unit
B106	New Developments In Lung Disease Genetics
B107	Biomarkers And Predictors Of Outcomes In Pulmonary Hypertension
B108	Diagnostic And Therapeutic Approaches In Sleep Apnea
B109	Sleep Disordered Breathing And Cardiovascular Disease: Of Rodents And Humans
B110	Genomics, Metabolomics, And Epigenetics In Lung Disease: Late Breaking Abstracts

TUESDAY, MAY 22

SUNRISE SEMINARS
7:00 am – 8:00 am

SS201	Targeting The Protease/Antiprotease Imbalance In COPD
SS202	Practical Applications Of Technology In Medical Education
SS203	Management Of Extra-Pulmonary Sarcoidosis: Neurologic, Cardiac, Hepatic, Hypercalcemia And Fatigue
SS204	Lung Transplant 101
SS205	The Bronchoscopist's Evolving Role In Lung Cancer Diagnosis And Therapeutic Decisions
SS206	The Art Of Prognostication: Understanding The Impact Of Comorbidities On Patient Outcome
SS207	Key Concepts In Cost Effectiveness And Decision Analysis: A Practical Approach For The Practicing Clinician
SS208	COPD, Asthma, Or Something In Between?
SS209	The Use Of Non-Physician Providers In The ICU
SS210	Hantavirus Cardiopulmonary Syndrome
SS211	Flexible Bronchoscopy In The Pediatric Intensive Care Unit
SS212	Pulmonary Hypertension Due To Left Heart Disease: Prognosis And Management
SS213	Pulmonary Rehabilitation For The Surgical Patient
SS214	Of Mice And Men: Therapeutic Implications Of Preclinical Models Of IPF
SS215	Obesity And Asthma: What Can We Learn From Animal Models?
SS216	Too Tired For 18 Wheels: Case Studies Of Sleep Apnea In Commercial Truck Drivers

THEMATIC SEMINARS SERIES
7:00 am – 8:00 am

TSS2	Drug-Induced Lung Disease

YEAR IN REVIEW
8:15 am – 10:15 am

C1	Clinical Year In Review 3

CLINICAL TOPICS IN PULMONARY MEDICINE
8:15 am – 10:45 am

C2	Pulmonary Fibrosis: When It’s Not Idiopathic Pulmonary Fibrosis
C3	Newly Recognized And Emerging Lung Diseases

CRITICAL CARE TRACK
8:15 am – 10:45 am

C4	Acute Kidney Injury In The Intensive Care Unit

SCIENTIFIC SYMPOSIA
8:15 am – 10:45 am

C5	Revisiting The IDSA-ATS Community-Acquired Pneumonia Guidelines: 5 Years Older, But Any Wiser?
C6	Inflammation And Altered Metabolism In Pulmonary Hypertension
C7	Developmental Control Of Respiratory Structure And Function During The Course Of Life
C8	No Pain No Gain: Will Upper-Airway Exercise Training/Electrical Stimulation Work For Sleep Apnea?
C9	Pulmonary Rehabilitation Across The Spectrum Of Illness For Patients With Chronic Obstructive Pulmonary Disease
C10	Implementing Lung Cancer Screening: Moving From RCTS To The Real World
C11	Imag(in)e The Lung: New Methodologies For Real-Time Visualization Of The Lung In Experimental Animals And Patients
C12	Tobacco Dependence In Pediatrics: What Can Be Done To Help Our Children And Their Parents?

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 am – 10:45 am

C13	Mechanisms Involved In Exacerbation Of Asthma And COPD
C14	Clinical Trials In Critical Care
C15	Predictors For COPD Progression And Outcomes
C16	Best Of Pediatrics
C17	Cellular And Molecular Signaling In The Pulmonary Endothelium Regulating Proliferation And Programmed Cell Death
C18	Emerging Pathways And Secondary Hits In Pulmonary Fibrosis
C21	Asthma Biomarkers
C22	Asthma Therapy
C23	COPD Comorbidities: Expanding The Horizons
C24	This Can Be Done Better: Quality, Safety And Process Improvement In Critical Care
C25	Advances In Non-Tuberculous Mycobacteria: Non-Tuberculous Mycobacteria Disease
C26	From PCP To COPD: Pulmonary Complications Of HIV Infection
C27	Evaluation And Management Of Difficult Asthma Populations
C28	Diagnosis And Treatment Of Pulmonary Hypertension
C29	Fat Signals: Crosstalk Between The Adipose Tissue And The Lung
C30	The Role Of The Smooth Muscle Cell In Airway Disease

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 AM – 4:30 PM

C31	Regulation Of Lung Inflammation
C32	Refractory Asthma
C33	Rhinitis, Sinusitis And Other Co-Morbidities
C34	Asthma Therapy: New Findings On Established Treatments
C35	Bacterial Pneumonia
C36	Lung Epithelium, Submucosal Glands And Smooth Muscle
C37	Mediators Of Asthma And Allergic Lung Disease
C38	Advances In Asthma And COPD Screening And Monitoring
C39	COPD Evaluation: Imaging
C40	COPD: Alpha 1 Antitrypsin
C41	Outcomes In Interstitial Lung Disease
C42	Case Reports: Tumors
C43	Lung Cancer: Diagnosis, Staging, Treatment And Outcomes
C44	Lymphangioleiomyomatosis And Other Cystic Lung Diseases: Clinical Features And Evolving Therapies
C45	Exacerbations Of COPD: Susceptibility And Pathogenesis
C46	Idiopathic Pulmonary Fibrosis: Pathogenesis And Comorbidities
C47	Topics In Transplant Medicine
C48	Bronchoscopy For Benign Disorders
C49	Interstitial Lung Disease: Supplemental Oxygen And Other Therapies
C50	COPD: Biomarkers
C51	Comorbidities In COPD
C52	COPD Pathogenesis: Human Studies
C53	COPD Pathogenesis: In Vitro And In Vivo Studies
C54	Case Reports: Interventional Pulmonology
C55	Interstitial Lung Disease: Diagnostic And Therapeutic Considerations
C56	Pulmonary And Non-Pulmonary Critical Care: Great Cases!
C57	Cardiopulmonary Interactions In The Intensive Care Unit
C58	Environmental Exposures: Mechanisms
C59	Occupational And Environmental Lung Disease
C60	Advances In Diagnosis Of Active Tuberculosis Disease
C61	Immunodiagnostics For Latent Tuberculosis Infection And Tuberculosis
C62	Experimental Models In Pulmonary Hypertension II
C63	Management Of Pulmonary Hypertension
C64	Pulmonary Vascular Structure, Function, And Signaling
C65	Peripheral Muscle Dysfunction
C66	Integrated Care And Pulmonary Rehabilitation
C67	Translational "Omics" Discoveries In Lung Disease
C68	Old And New Pathways To Pulmonary Fibrosis
C69	Cellular Signaling Of Oxidative Stress
C70	Repair And Regeneration: Stem Cell Functions And Applications
C71	Major Impact Of Micro-RNA Function
C72	Sleep And Sleep Disordered Breathing In Other Medical Disorders
C73	Sleep Disordered Breathing: Epidemiology And Outcomes

WORKSHOPS
11:30 am – 1:00 pm

WS5	Models Of Sleep Apnea Care Utilizing Portable Monitoring And Alternative Delivery Methods
WS6	Pulmonary Evaluation And Respiratory Support In Amyotrophic Lateral Sclerosis (ALS)

MEET THE PROFESSOR SEMINARS
12:00 pm – 1:00 pm

MP601	Stress And Childhood Asthma: Is It Time To Consider Clinical Interventions?
MP602	Publish Without Perishing: A Guide To What Those Darn Editors Want
MP603	Management Of Pulmonary Nodules, Including Nodules Identified During Lung Cancer Screening And Ground Glass Opacities
MP604	Drug-Induced/Iatrogenic Respiratory Disease
MP605	Case-Based Approach To Pulmonary Mac and M.Abscessus Infection
MP606	Acute Exacebation Of Idiopathic Pulmonary Fibrosis: Concept And Management
MP607	Therapeutic Bronchoscopy For Benign And Malignant Airway Obstruction: The Nuts And Bolts
MP608	Pneumonia: From The Emergency Department To The Hospital
MP609	Can ARDS Be Prevented?
MP610	Investigation And Management Of Occupational Asthma
MP611	Management Of Ventilator Associated Pneumonia: State Of The Art From Experts
MP612	Children's Interstitial And Diffuse Lung Disease In The Critical Care Unit
MP613	Management Of Right Heart Failure In The ICU
MP614	The Management of Refractory Dyspnea In Advance COPD
MP615	GM-CSF Inhalation As A Less Invasive Treatment For Pulmonary Alveolar Proteinosis
MP616	Adiponectin In Asthma: Beneficial Role Or Innocent Bystander?
MP617	Continuous Positive Airway Pressure (CPAP) Use In Children
MP618	Updates In Fungal Infections, From Bench To Bedside
MP619	Improving The Early Diagnosis Of Pulmonary Hypertension

THEMATIC SEMINAR SERIES
12:00 pm – 1:00 pm

TSS2	Drug-Induced Lung Disease

YEAR IN REVIEW
2:00 pm – 4:30 pm

C81	Nursing Year In Review: Interdisciplinary Research: Moving From Silos To Synergy

CLINICAL TOPICS IN PULMONARY MEDICINE
2:00 pm – 4:30 pm

C82	Pulmonary And Non-Pulmonary Manifestations Of Hyperinflation In Chronic Obstructive Pulmonary Disease: Pathogenesis And Implications For Treatment
C83	Pediatric Clinical Chest Rounds

CRITICAL CARE TRACK
2:00 pm – 4:30 pm

C84	Using Genomics To Understand And Treat Acute Lung Injury

SCIENTIFIC SYMPOSIA
2:00 pm – 4:30 pm

C85	Quality And Performance Measures: The Future Of Healthcare
C86	Severe Asthma: A View To The Future Consultation
C87	Hypoxia And Neurocognitive Impairment: Lessons From Sleep Apnea And Ischemic Brain Injury
C88	Lung Cancer Stem Cells And The Role Of The Microenvironment In Lung Carcinogenesis
C89	Evidence-Based Innovations In Tuberculosis Diagnosis And Treatment
C90	Pro-Con Debate: Comparative Effectiveness Research: Fool's Gold Or Promise Land?

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
2:00 pm – 4:30 pm

C92	Control Of Macrophage Polarization And Effector Functions
C93	Evolving Role Of Screening For Lung Cancer
C94	From Bay To Breaking Intensive Care Unit Capacity: Staffing, Strains And Stemming The Tide
C95	Novel Insights Into Influenza Pathogenesis
C96	Bone Marrow And Microparticles In The Pathogenesis Of Pulmonary Arterial Hypertension
C97	Mechanism And Outcomes Of Cellular Autophagy
C98	Novel Airway Epithelial Barrier And Immune Responses
C101	Transplant And Ischemia And Reperfusion Related Lung Injury
C102	Quality Improvement In Pulmonary Medicine
C103	Pathogenesis, Biomarkers, And Risk Factors For Interstitial Lung Disease: From Bench To Bedside
C104	Case Reports: Interventional Pulmonology And Pleural Diseases
C105	Ethics And End-Of-Life Care In The Intensive Care Unit
C106	Determinants Of Control And Severity Of Asthma And COPD
C107	Progress In Biomarkers And Diagnostics For Respiratory Infections
C108	Pediatric Cystic Fibrosis And Primary Ciliary Dyskinesia
C109	Effects Of Senescence And Manifestations Of Aging In The Lung
C110	Skeletal Muscle Dysfunction In Chronic Pulmonary Disease: Adaptation Or Maladaptation?

WEDNESDAY, MAY 23

SUNRISE SEMINARS
7:00 am – 8:00 am

SS301	Asthma Exacerbations: Risks, Biomarkers And Management Strategies
SS302	Rheumatoid Arthritis Related Interstitial Lung Diseases
SS303	Introduction To Quality Improvement
SS304	Connective Tissue Disease And The Lung: Lessons Learned From Difficult Cases
SS305	Is Sleep Apnea Affecting My Brain? Impact Of OSAS On Neurocognitive Function
SS306	Antisynthetase Syndrome
SS307	Managing Patient Care And Complications After Lung Transplantation
SS308	Mortality And The Cardiovascular Effects Of Acute Exacerbation Of COPD
SS309	Pulmonary Embolism: To Lyse Or Not?
SS310	Are Diseased Airway Epithelial Cells More Susceptible To Air Pollutants?
SS311	Sleep Disordered Breathing In Pediatric Neuromuscular Disease
SS312	Genetics Of Pulmonary Arterial Hypertension: Relevance To Clinical Practice
SS313	Mitochondrial Metabolism: A Novel Therapeutic Target In Chronic Lung Disease
SS314	L-Arginine Homeostasis: Novel Master Switch In Respiratory Structure And Function?
SS315	Stroke As A Sequela Of Sleep Pathology

YEAR IN REVIEW
8:15 am – 10:15 am

D1	Clinical Year in Review 4

CLINICAL TOPICS IN PULMONARY MEDICINE
8:15 am – 10:45 am

D2	Mechanisms And Implications Of Mucus Accumulation In Chronic Obstructive Pulmonary Disease
D3	The SPN In 2012: The State Of The Art In The Evaluation Of The Pulmonary Nodule

CRITICAL CARE TRACK
8:15 am – 10:45 am

D4	Intensive Care Of The Future

SCIENTIFIC SYMPOSIA
8:15 am – 10:45 am

D5	Addressing Variability In Asthma Treatment Responses: Implementing An Individualized Approach
D6	Behavioral Sciences Year In Review: Celebrating The BSA's 20th Anniversary
D7	Alveolar Epithelium In Fibrotic Lung Remodeling: Innocent Bystander Or Key Player?
D8	Epigenetic Targets For Novel Therapy Of Lung Diseases
D9	Controversies In The Diagnosis And Treatment Of Sickle Cell Lung Disease
D10	Inhaled Exposures, Genetics And Airways Disease: A View Towards Prevention
D11	Critical Care In The Immunocompromised Host
D12	The Changing World Of Drug Discovery And Development

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 am – 10:45 am

D13	Scientific And Clinical Innovations In Lung Transplantation
D14	Advances In Pleural Infection And Malignancy
D15	Surgical And Bronchoscopic Lung Volume Reduction: State Of The Art
D16	Cystic Fibrosis: Biomarkers, Outcome Measures, And Pathogenesis
D17	Sleep Disordered Breathing Pathogenesis: Mechanical And Neural Mechanisms
D18	Sleep Disordered Breathing And Metabolic Function: How Unsweet It Is
D21	Microbial Contributions To Asthma Pathogenesis
D22	Pathogenesis Of Lung Fibrosis And Airway Remodeling
D23	Case Reports: Interstitial Lung Disease
D24	The Villain Behind Ventilator-Induced Lung Injury
D25	Pulmonary Infections And Tuberculosis: Case Reports Of Note
D26	Pediatric Respiratory Infections
D27	Signaling Molecules Involved In Pulmonary Endothelial Injury And Repair
D28	Developmental Signaling Reborn In Adult Lung Disease
D29	Sticky Situation: Multi-Fate Of Cell And Matrix Interactions
D30	Novel Approaches To Assessing Lung Pathophysiology

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
8:15 AM – 4:30 PM

D31	Advances In Asthma Genetics
D32	Aerosols Therapy
D33	Asthma Pathogenesis
D34	Asthma Epidemiology
D35	Phosphodiesterase Inhibitors As Therapeutics For Lung Diseases
D36	Influences And Outcomes Of Respiratory Viral Infections
D37	What's New In Fibrosis And Pneumonitis?
D38	Mast Cells And Basophils In Asthma And COPD
D39	Evaluation And Monitoring Of Asthma And COPD
D40	Sepsis
D41	Developing And Improving Measures To Assess And Change Beliefs, Skills, Behaviors And Outcomes
D42	COPD Treatment: Oxygen, Home Ventilation And Others
D43	Pulmonary Alveolar Proteinosis
D44	Clinical Application Of Pulmonary Physiological Studies
D45	Acute Exacerbations Of Idiopathic Pulmonary Fibrosis
D46	Case Reports: Lung Transplantation
D47	Issues In Thoracic Surgery
D48	Chronic Cough
D49	Impact Of COPD Exacerbation On Comorbidities
D50	Genetic Studies In COPD
D51	COPD: Diagnosis And Evaluation
D52	Case Reports: Pleural Diseases
D53	Interstitial Lung Disease Case Reports: Sometimes The Hoof Beats Indicate Zebras
D54	Topics In Interventional Pulmonology
D55	From The White Elephant To The Common Canary: Presentation And Outcomes Of Common And Not-So-Common Critical Illnesses
D56	Intensive Care Unit Procedures, Ultrasound, And New Devices
D57	Sepsis: Of Mice, Metabolomics, And Man
D58	Extracorporeal Membrane Oxygenation: Resting Injured Lungs
D59	COPD Epidemiology: Risk Factors, Trends, Comorbidities
D60	Health Effects Of Smoking
D61	Respiratory Clinical Epidemiology
D62	Nosocomial Infections: Bacteriology, Drug Resistance, And Outcomes
D63	Advances In Treatment Of Respiratory Infections
D64	New Insights Into Mechanisms, Complications And Outcomes Of Bronchiectasis
D65	Case Reports Of Unusual Pulmonary Infections
D66	General Pediatric Pulmonary
D67	Pediatric Pulmonary Physiology And Measurement
D68	Pulmonary Vascular Diseases: Clinical Cases
D69	Pulmonary Embolism And Chronic Thromboembolic Pulmonary Hypertension
D70	Mechanical Forces And Hemodynamics In Response To Exercise
D71	Animal Models Of Lung Fibrosis: Bleo And Beyond
D72	Cell Fate Decisions: Apoptosis Vs. Survival Of Structural Cells Of The Lung
D73	Receptor Input Of Airway Networking
D74	Molecular Targets And Model Therapies For Lung Cancer
D75	Mucins: Novel Pathways Of Regulation And Previously Unsuspected Functions
D76	Alveolar Epithelium: Novel Tools And Phenotypes
D77	Airway Cell Differentiation And Injury: Two Sides Of A Coin
D78	Pathways And Models Of Lung Oncogenesis
D79	Exercise, Hypoxia And Altitude
D80	Emphysema And COPD: Pathophysiology
D81	Assessing The Airways
D82A	Sleep Disordered Breathing: Diagnosis
D82B	Management Of Sleep Disordered Breathing

WORKSHOPS
11:30 am – 1:00 pm

WS7	Innovative Teaching And Evaluation Methods
WS8	Clinical Impact Of Point Of Care Ultrasonography In Critically Ill Patients

SESSIONS BY OTHER ORGANIZATIONS
12:00 pm – 1:00 pm

L18	Ancillary Studies Of The American Lung Association Asthma Clinical Research Centers
L19	Overview By The Environmental Protection Agency On Recent Actions And The Agency's Research Program
L20	Counteract Research Program At NIEHS/NIH
L21	U.S. Critical Illness And Injury Trials (USCIIT) Group: Clinical Trials Update
L22	Pulmonary Research At The VA
L23	Idiopathic Pulmonary Fibrosis Network IPFNet: New Insights Into IPF
L24	Major Scientific Advances From NHLBI ARRA-Funded Challenge Grants
L25	Sleep Heart Health Study: Key Discoveries And Scientific Opportunities
L28	ARDS Consensus Conference: New Definition and Disease Stratification

CLINICAL TOPICS IN PULMONARY MEDICINE
2:00 pm – 4:30 pm

D83	Pneumonia And Pleural Infection: Advances And Controversies

CRITICAL CARE TRACK
2:00 pm – 4:30 pm

D84	What Are The Boundaries Of Acceptable Medical Practice Near The End Of Life In Intensive Care Units?

SCIENTIFIC SYMPOSIA
2:00 pm – 4:30 pm

D85	Hypersensitivity Pneumonitis: Recent Advances, Future Directions
D86	Impact Of Exercise On Cardiopulmonary Status: Implications For Pulmonary Hypertension
D87	Intermittent Hypoxia Mediated Cardiovascular And Neuronal Protective Mechanisms
D88	Imaging Structure And Function Via MRI, CT, And PET
D89	Live And Let Die: Linking Endoplasmatic Stress, Autophagy, And Apoptosis In Lung Health And Disease

ORAL AND POSTER PRESENTATIONS OF SCIENTIFIC RESEARCH AND CASE REPORTS
2:00 pm – 4:30 pm

D92 Novel Mediators In Asthma Pathogenesis D93 Early Origins Of Asthma D94 Non-Invasive Ventilation And Weaning By The Bay D95 How Do Dietary Factors And Obesity Influence Lung Disease? D96 What's New In Tuberculosis Diagnostics D97 Pulmonary Hypertension: New Insights Into Causes And Treatments? D98 Novel Mechanisms Of Tumor Promotion And Molecular Targeted Therapy In Lung Cancer D99 Repair By Stem Cells: Paracrine Mechanisms And Induced Pluripotent Stem Cells (IPSCS) D100 The Big Role Of Small Airways D101 Animal Models Of Emphysema D102 Quality Improvement In Critical Care Medicine D103 Case Reports: General Pulmonary D104 Connective Tissue Disease Related-Interstitial Lung Disease: Clinical Features And Treatment D105 COPD: Phenotypes And Outcomes D106 Case Reports: Tumors D107 Pediatric Sleep Disorders D108 Out Of Control: Proliferative And Fibrotic Remodeling Of The Lung D109 Sleep Disordered Breathing And Heart Failure: Mechanisms, Consequences, And Treatment